
Sign up to save your podcasts
Or


Anteris CEO explains why their new biomimetic heart valve can take serious market share in a $10 billion market. It's currently implanted in over 100 patients, and surgeons are delighted with the results. The market is sleeping on this one...
By Michael Frazis3.7
33 ratings
Anteris CEO explains why their new biomimetic heart valve can take serious market share in a $10 billion market. It's currently implanted in over 100 patients, and surgeons are delighted with the results. The market is sleeping on this one...

3,230 Listeners

9 Listeners

13 Listeners

86 Listeners

20 Listeners

42 Listeners

394 Listeners

14 Listeners

60 Listeners

26 Listeners

24 Listeners

4 Listeners

7 Listeners

10 Listeners

22 Listeners